News Sentiment

AMIX sentiment intelligence

Autonomix Medical, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 6.57 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

+2.2% over one week, -18.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction 2.2% Price confirming higher
Trend fit Trend inactive -18.9% over four weeks
Fair value -97.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 34
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 9
GlobeNewswire 6
TradingView 4
MT Newswires 3
StockStory 3
MSN 2
Kalkine 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 21
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
TradingView Direct company coverage

Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants

Autonomix Medical (AMIX) has secured approximately $2.6 million in gross proceeds through a warrant inducement letter. The company reduced the exercise price of existing Series C warrants to $6.00 and issued new Series D-1 and D-2 warrants for 428,731 shares each, with an exercis

Tone
Positive 66/100
Event
Market update
Published
15 Jul 2026 21:13
Source
TradingView
Investing.com Nigeria Direct company coverage

Autonomix Medical receives patent for overactive bladder device By Investing.com

Autonomix Medical Inc. (NASDAQ:AMIX) has been granted a patent for a catheter-based system to diagnose and treat overactive bladder, expanding its platform technology into a significant clinical market. Despite the company's stock experiencing a significant drop, InvestingPro ana

Tone
Positive 65/100
Event
Market update
Published
15 Jul 2026 14:13
Source
Investing.com Nigeria
GlobeNewswire Direct company coverage

Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform

Autonomix Medical, Inc. announced it has been granted a U.S. patent for a new platform designed for the diagnosis and treatment of overactive bladder (OAB), a condition affecting approximately 37 million Americans. The patented system uses a catheter-based approach for minimally

Tone
Positive 80/100
Event
Market update
Published
15 Jul 2026 13:11
Source
GlobeNewswire
Stock Titan Direct company coverage

Autonomix Patent Covers Catheter That Maps and Treats Bladder Nerves

Autonomix Medical (NASDAQ: AMIX) has been granted a U.S. patent for a platform designed to diagnose and treat overactive bladder (OAB), expanding its neural sensing and therapeutic technology into urology. The patent covers a catheter-based system for nerve mapping and targeted t

Tone
Positive 75/100
Event
Market update
Published
15 Jul 2026 11:59
Source
Stock Titan
GlobeNewswire Direct company coverage

Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules

Autonomix Medical, Inc. announced a warrant inducement agreement resulting in an immediate exercise of outstanding warrants from November 2025. This agreement is expected to generate approximately $2.6 million in gross proceeds and involves the issuance of new unregistered Series

Tone
Positive 66/100
Event
Market update
Published
14 Jul 2026 01:42
Source
GlobeNewswire
Stock Titan Direct company coverage

Investor Agrees to Exercise 428,731 Autonomix Warrants

Autonomix Medical (NASDAQ: AMIX) has entered into a warrant inducement agreement with an existing investor for the immediate cash exercise of 428,731 outstanding warrants at an amended exercise price of $6.00 per share, expected to generate approximately $2.6 million in gross pro

Tone
Negative 39/100
Event
Balance sheet
Published
14 Jul 2026 01:42
Source
Stock Titan
Market source Direct company coverage

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant

Autonomix Medical has secured a new Canadian patent, "Endoscopic Sympathectomy Systems and Methods," expanding its global intellectual property portfolio to 112 issued or pending patent applications. This patent enhances the company's position in neural sensing and precision nerv

Tone
Positive 93/100
Event
Market update
Published
13 Jul 2026 12:42
Source
Market source
Proactive financial news Direct company coverage

Autonomix Medical wins new patent for neural sensing technology

Autonomix Medical Inc. (NASDAQ:AMIX) has secured a new patent for its neural sensing technology, enhancing its intellectual property in the denervation market. This patent reinforces the company's leadership in the multi-billion-dollar denervation market by legally protecting its

Tone
Positive 71/100
Event
Market update
Published
13 Jul 2026 12:40
Source
Proactive financial news
Quiver Quantitative Direct company coverage

Autonomix Medical Announces Canadian Patent Grant Strengthening Its Real-Time Nerve Sensing and Denervation IP Portfolio

Autonomix Medical Inc. has been granted Canadian Patent No. 3,158,197, titled "Endoscopic Sympathectomy Systems and Methods," expanding its global intellectual property portfolio to 112 patents. This new patent enhances its real-time nerve sensing, mapping, and neuromodulation te

Tone
Positive 70/100
Event
Market update
Published
13 Jul 2026 11:40
Source
Quiver Quantitative
Stock Titan Direct company coverage

New Autonomix patent targets nerves behind hypertension and heart, kidney disease

Autonomix Medical (NASDAQ: AMIX) has been granted Canadian Patent No. 3,158,197 for "Endoscopic Sympathectomy Systems and Methods," enhancing its global intellectual property portfolio for nerve-targeted therapies. This patent strengthens the company's position in real-time nerve

Tone
Negative 30/100
Event
Market update
Published
13 Jul 2026 11:39
Source
Stock Titan
The Globe and Mail Direct company coverage

Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status

Autonomix Medical, Inc. (AMIX) has successfully regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. The company's stock maintained a closing price of $1.00 or higher for 10 consecutive business days, resolv

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 08:06
Source
The Globe and Mail
TradingView Direct company coverage

Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak

Autonomix Medical (AMIX) has regained compliance with Nasdaq's $1.00 bid-price rule. This followed its stock closing at or above $1.00 for ten consecutive business days, from June 24 to July 8, 2026. The matter is now closed, confirming the company's compliance with Rule 5550(a)(

Tone
Positive 77/100
Event
Market update
Published
10 Jul 2026 12:39
Source
TradingView
Stock Titan Direct company coverage

Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance

Autonomix Medical (NASDAQ: AMIX) has regained compliance with Nasdaq's minimum bid price requirement for listing on the Nasdaq Capital Market. The company received a deficiency notice on January 14, 2026, after its common stock fell below $1.00 per share for 30 consecutive busine

Tone
Positive 70/100
Event
Market update
Published
10 Jul 2026 12:39
Source
Stock Titan
Finviz Direct company coverage

AMIX - Autonomix Medical Inc Options

This article provides a detailed financial overview of Autonomix Medical Inc. (AMIX), including its last close price, percentage change, market capitalization, key financial ratios, earnings per share data, and performance metrics over various periods. It also lists insider and i

Tone
Negative 40/100
Event
Earnings
Published
04 Jul 2026 09:42
Source
Finviz
Finviz Direct company coverage

AMIX - Autonomix Medical Inc Latest SEC Filings

This article provides detailed financial and stock performance data for Autonomix Medical Inc (AMIX) as of July 2, 2024. It covers key metrics such as market cap, income, sales, EPS, various ratios, insider ownership, and stock performance over different periods. The data indicat

Tone
Negative 30/100
Event
Earnings
Published
03 Jul 2026 21:40
Source
Finviz
TradingView Direct company coverage

Enterprise value to EBIT forward of Autonomix Medical, Inc. – NASDAQ:AMIX

This article provides financial information for Autonomix Medical, Inc. (NASDAQ: AMIX), specifically focusing on its enterprise value to EBIT forward. It appears to be a financial data page from TradingView, displaying stock market information and company financial metrics.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 09:42
Source
TradingView
TradingView Direct company coverage

Price to book forward of Autonomix Medical, Inc. – NASDAQ:AMIX

The article presents financial information for Autonomix Medical, Inc. (NASDAQ: AMIX), specifically focusing on its price to book forward. It is a brief entry from TradingView, displaying market status and financial data for the company.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 23:41
Source
TradingView
Stock Titan Direct company coverage

Autonomix Medical (AMIX) consolidates shares in 1-for-21 reverse stock split

Autonomix Medical (AMIX) has announced a 1-for-21 reverse stock split, effective June 24, 2026, which will reduce its outstanding common shares from approximately 11.4 million to 542,000. Each 21 shares will be combined into one, with fractional shares being compensated in cash,

Tone
Neutral 50/100
Event
Balance sheet
Published
24 Jun 2026 11:09
Source
Stock Titan
Market source Direct company coverage

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

Autonomix Medical has announced a standalone neural sensing program, building on preclinical results that demonstrated real-time detection of renal neural activity changes. This platform, which leverages the core sensing technology from their pancreatic cancer pain program, aims

Tone
Positive 73/100
Event
Earnings
Published
22 Jun 2026 12:12
Source
Market source
Stock Titan Direct company coverage

Autonomix sees real-time renal nerve activity changes in preclinical tests

Autonomix Medical (NASDAQ: AMIX) has announced a proprietary standalone neural sensing platform, showcasing preclinical evidence of detecting real-time renal nerve activity and changes post-intervention. This platform, built on the company's core technology, initially targets ren

Tone
Positive 72/100
Event
Market update
Published
22 Jun 2026 12:12
Source
Stock Titan
GlobeNewswire Direct company coverage

Autonomix Medical Announces Standalone Neural Sensing

Autonomix Medical, Inc. announced the development of a proprietary standalone neural sensing platform, following preclinical results demonstrating its ability to identify renal neural activity and detect real-time changes post-intervention. This platform, built on the same core t

Tone
Positive 73/100
Event
Earnings
Published
22 Jun 2026 08:00
Source
GlobeNewswire